DE69621447D1 - Verwendung von nitroflavonoide zur behandlung von angstzuständen - Google Patents

Verwendung von nitroflavonoide zur behandlung von angstzuständen

Info

Publication number
DE69621447D1
DE69621447D1 DE69621447T DE69621447T DE69621447D1 DE 69621447 D1 DE69621447 D1 DE 69621447D1 DE 69621447 T DE69621447 T DE 69621447T DE 69621447 T DE69621447 T DE 69621447T DE 69621447 D1 DE69621447 D1 DE 69621447D1
Authority
DE
Germany
Prior art keywords
nitroflavonoids
anxieties
treating
treating anxieties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69621447T
Other languages
English (en)
Other versions
DE69621447T2 (de
Inventor
Alejandro Constantino Paladini
Jorge Horacio Medina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Publication of DE69621447D1 publication Critical patent/DE69621447D1/de
Application granted granted Critical
Publication of DE69621447T2 publication Critical patent/DE69621447T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
DE69621447T 1995-10-17 1996-10-16 Verwendung von nitroflavonoide zur behandlung von angstzuständen Expired - Lifetime DE69621447T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9521184.3A GB9521184D0 (en) 1995-10-17 1995-10-17 Flavonoids
PCT/GB1996/002523 WO1997014414A1 (en) 1995-10-17 1996-10-16 Use of nitroflavonoids for the treatment of anxiety

Publications (2)

Publication Number Publication Date
DE69621447D1 true DE69621447D1 (de) 2002-07-04
DE69621447T2 DE69621447T2 (de) 2003-05-08

Family

ID=10782385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621447T Expired - Lifetime DE69621447T2 (de) 1995-10-17 1996-10-16 Verwendung von nitroflavonoide zur behandlung von angstzuständen

Country Status (9)

Country Link
US (1) US6080780A (de)
EP (1) EP0857066B1 (de)
JP (1) JP4745468B2 (de)
AU (1) AU7310896A (de)
DE (1) DE69621447T2 (de)
ES (1) ES2177811T3 (de)
GB (1) GB9521184D0 (de)
WO (1) WO1997014414A1 (de)
ZA (1) ZA968773B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9707013D0 (en) * 1997-04-07 1997-05-28 Univ Strathclyde Halo and/or nitro-substituted flavonoids
US7183314B1 (en) 2000-07-21 2007-02-27 Naturon Limited Compound for treatment of anxiety and methods of preparation and use thereof
RU2209062C1 (ru) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Вещество, обладающее седативным действием
GB0216371D0 (en) * 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
US20050080024A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20040033480A1 (en) * 2002-08-15 2004-02-19 Wong Norman C.W. Use of resveratrol to regulate expression of apolipoprotein A1
US20050080021A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids
WO2007056188A1 (en) * 2005-11-04 2007-05-18 President And Fellows Of Harvard College Synthesis of inhibitors of ftsz
WO2008147483A2 (en) * 2007-02-14 2008-12-04 Mars, Incorporated Neurogenic compounds
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
KR20190022085A (ko) * 2017-08-25 2019-03-06 건국대학교 글로컬산학협력단 타마리세틴을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317071D0 (en) * 1993-08-17 1993-09-29 Univ Strathclyde Flavonoids

Also Published As

Publication number Publication date
JP4745468B2 (ja) 2011-08-10
GB9521184D0 (en) 1995-12-20
US6080780A (en) 2000-06-27
ZA968773B (en) 1997-05-27
AU7310896A (en) 1997-05-07
ES2177811T3 (es) 2002-12-16
JP2000505055A (ja) 2000-04-25
DE69621447T2 (de) 2003-05-08
WO1997014414A1 (en) 1997-04-24
EP0857066A1 (de) 1998-08-12
EP0857066B1 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69636674D1 (de) Vorrichtung zur wärmebehandlung von gewebe
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69603838T2 (de) Verfahren zur behandlung von gasen
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69630321D1 (de) Vorrichtung zur örtlichen wärmebehandlung von gewebe
DE69433793D1 (de) Phosphorderivate zur behandlung von aids
DE69526935D1 (de) Verwendung von mycobacterium zur tumorbehandlung
DE69621447T2 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69521576D1 (de) Vorrichtung zur aeroben Behandlung von Abwasser
ATE204705T1 (de) Pflaster zur behandlung von pflanzen
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE59705697D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
DE69607559T2 (de) Verfahren zur Behandlung von Phenolteer
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69701458D1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE69430545D1 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
DE59904564D1 (de) Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition